SEAMEC III sails for second phase of pipeline replacement

On December 18, the company announced that it had given a letter of award to Adsun Offshore Diving Contractors Pvt Ltd for providing diving-related services on board the vessel Seamec III.

On December 18, the company announced that it had given a letter of award to Adsun Offshore Diving Contractors Pvt Ltd for providing diving-related services on board the vessel Seamec III.

Nike Inc. rose and was the top-performer in the market after Apple Inc. CEO Tim Cook purchased $2.95 million in shares. Cook, who is Nike’s lead independent director, nearly doubled the number of shares he owns in the company.

The yield for the tenor fell 1.5 basis points to 1.085% in morning Tokyo trading, while yields for the 10-year bond are down 3 basis points. Those for longer tenors all dropped by as much as 4.5 basis points.

After a flat opening, early buying pushed Nifty to an intraday high of 26,235 within the first hour of trade. However, sentiment weakened after 10:30 am, with selling pressure dragging the index more than 100 points off its highs.

Sebi doubles threshold for simplified duplicate securities issuance to ₹10 lakh, streamlines documentation, and mandates demat form for all duplicates, easing investor compliance for listed companies.

Aluminium is entering 2026 with strong fundamentals as structural demand from electric vehicles, renewable energy, and electrification coincides with persistent supply constraints. With global inventories at multi-year lows and production growth limited, the market is expected to remain in deficit,…

IndiGo stabilises operations, adds flights for holiday surge, manages fog disruptions, and prepares to launch Airbus A321XLR routes to Athens in 2026. The airline is currently operating between 2,100 and 2,200 flights daily.

Panacea Biotech received an update to its UNICEF contract for supplying the WHO pre-qualified pentavalent vaccine, Easyfive-TT (DTwP-HepB-Hib), for 2023-2027. Shares of Panacea Biotech closed at ₹359.50, up 0.93% on the NSE today, December 24.

Strides Pharma Science Ltd’s Chestnut Ridge facility received four procedural FDA observations, with no impact on supply. Shares of Strides Pharma Science Ltd ended lower on Wednesday, December 24, by 3.59% at ₹936 on the NSE.

Indian equity markets may have delivered muted returns in 2025, but the year offered critical lessons for investors on diversification, disciplined buying during corrections, and the risks of chasing past performance. Market experts say portfolios backed by asset allocation and…